Should dividend investors hold on to Abbott (ABT) and Abbvie (ABBV) following the split?
by | Posted 2.4.2013 | Post Comment (No Comments)

I have been a shareholder of Abbott Laboratories for several years. I liked the fact that the company was constantly undervalued, and also managed to offer a very attractive yield plus an above average dividend growth. My last addition to my position occurred in the final weeks of 2012. In my last analysis of the stock, I was bullish on its business going forward.

Read the rest of this post @ DividendGrowthInvestor